HIMS: Hims & Hers Health, Inc. insider trading, 5% holders and institutional ownership
From public SEC filings: open-market insider purchases and sales (Form 4, last 180 days), holders of 5% or more (Schedules 13D and 13G) and institutional ownership (Form 13F). Insider and 5% data delayed 48 hours.
Insider trading
0 open-market buys totaling - and 3 sales totaling $261K in the last 180 days.
Insider sales
| Trade date | Insider | Role | Value | 10b5-1 plan |
|---|---|---|---|---|
| 2026-10-14 | Boughton Soleil | Officer | $101K | yes |
| 2026-10-01 | Okupe Oluyemi | CFO | $59K | yes |
| 2026-09-30 | Boughton Soleil | Officer | $101K | yes |
Activist and 5% holders
| Filed | What | Holder | Stake | Change | Filing |
|---|---|---|---|---|---|
| 2026-08-31 | 13D amendment | Andrew Dudum | 9.40% | SEC |
Get new insider and activist filings the morning after: daily alerts. Not investment advice.